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IMPORTANCE Enhanced Recovery After Surgery (ERAS) care has been reported to be
associated with improvements in outcomes after colorectal surgery compared with
traditional care.
OBJECTIVE To determine the association between ERAS protocols and outcomes in patients
undergoing elective colorectal surgery.
DESIGN, SETTING, AND PARTICIPANTS The Postoperative Outcomes Within Enhanced
Recovery After Surgery Protocol (POWER) Study is a multicenter, prospective cohort study of
2084 consecutive adults scheduled for elective colorectal surgery who received or did not
receive care in a self-declared ERAS center. Patients were recruited from 80 Spanish centers
between September 15 and December 15, 2017. All patients included in this analysis had 1
month of follow-up.
EXPOSURES Colorectal surgery and perioperative management were the exposures.
Twenty-two individual ERAS items were assessed in all patients, regardless of whether they
were included in an established ERAS protocol.
MAIN OUTCOMES AND MEASURES The primary study outcome was moderate to severe
postoperative complications within 30 days after surgery. Secondary outcomes included
ERAS adherence, mortality, readmissions, reoperation rates, and hospital length of stay.
RESULTS Between September 15 and December 15, 2017, 2084 patients were included in the
study. Of these, 1286 individuals (61.7%) were men; mean age was 68 years (interquartile range
[IQR], 59-77). A total of 879 patients (42.2%) presented with postoperative complications and
566 patients (27.2%) developed moderate to severe complications. The number of patients with
moderate or severe complications was lower in the ERAS group (25.2% vs 30.3%; odds ratio
[OR], 0.77; 95% CI, 0.63-0.94; P = .01). The overall rate of adherence to the ERAS protocol was
63.6% (IQR, 54.5%-77.3%), and the rate for patients from hospitals self-declared as ERAS was
72.7% (IQR, 59.1%-81.8%) vs non-ERAS institutions, which was 59.1% (IQR, 50.0%-63.6%;
P < .001). Adherence quartiles among patients receiving the highest and lowest ERAS
components showed that the patients with the highest adherence rates had fewer moderate to
severe complications (OR, 0.34; 95% CI, 0.25-0.46; P < .001), overall complications (OR, 0.33;
95% CI, 0.26-0.43; P < .001), and mortality (OR, 0.27; 95% CI, 0.07-0.97; P = .06) compared
with those who had the lowest adherence rates.
CONCLUSIONS AND RELEVANCE An increase in ERAS adherence appears to be associated with
a decrease in postoperative complications.
JAMA Surg. doi:10.1001/jamasurg.2019.0995
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A n estimated 310 million patients undergo surgery world-wide each year.1 The International Surgical OutcomesStudy reported that, globally, 26.8% of patients who un-
derwent major surgery had postoperative complications, and
24.3% of those who underwent low abdominal surgery devel-
oped complications.2 These findings are similar to those of a
previous study.3 Postoperative complications after major
surgery have been shown to increase the length of stay (LOS),
cost, and mortality.4-6 Moreover, the presence of postopera-
tive complications after colorectal surgery was associated with
decreased long-term survival, independent of patient, dis-
ease, and treatment factors.3
Enhanced Recovery After Surgery (ERAS) protocols or en-
hanced recovery pathways (ERPs) have become prevalent in
colorectal surgery. These programs combine use of a multi-
disciplinary team, protocolization of perioperative manage-
ment, and patient education.7
Single-center studies,8,9 multicenter observational
studies,10-12 and meta-analyses13 have reported that the ap-
plication of a perioperative ERP is associated with improve-
ments in postoperative outcomes. Many of the components of
the ERP could be considered as standard care14; neverthe-
less, there are still barriers for its full implementation,15 de-
spite health systems recommendations.16 Adherence to the in-
dividual items that make up an ERP in the perioperative period
has been associated with improvements in postoperative
outcomes,10,17 including with reductions in postoperative com-
plications and LOS.18,19
Although there is evidence that demonstrates the effec-
tiveness of the ERP,12 to our knowledge, there are no large case
series of patients showing better postoperative outcomes in cen-
ters that perform ERP successfully compared with centers that
have the same adherence rates to individual components that
make up an ERP as a whole, even though a predefined ERP is
not performed. Moreover, there is uncertainty regarding the rela-
tive benefit from each component of an ERP.
Therefore, the aim of this study was to characterize the
management strategies for treatment in patients who under-
went elective colorectal surgery in Spain, including centers with
and those without an established ERP, and analyze the asso-
ciation between the individual elements of the ERAS proto-
cols and postoperative complications.
The primary end point of the study was the incidence of
moderate to severe postoperative complications within 30 days
after surgery. Secondary end points were ERAS adherence, re-
admissions, reoperations, hospital length of stay, mortality, and
the occurrence of postoperative complications.
Methods
Study Design and Participants
The Postoperative Outcomes Within Enhanced Recovery Af-
ter Surgery Protocol (POWER) study was a prospective,
2-month, multicenter cohort study. The study was approved
by the Instituto Aragonés de Ciencias de la Salud Ethics Com-
mittee, Zaragoza, Spain and by the Spanish Medical Agency,
and was registered prospectively (NCT03012802). Ethics
committees or institutional review boards at each site reviewed
and approved the protocol. Written informed consent was
obtained for patients to take part in the study when required
by local ethics committees. Participants did not receive
financial compensation.
This study followed the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) reporting
guideline for cohort studies.20 Hospital and investigator
participation were facilitated through the Spanish Perioperative
Audit and Research Network, which was established by the
Grupo Español de Rehabilitación Multimodal. All Spanish
hospitals were invited to participate, regardless of the number
of beds and the existence of an ERP protocol.
Procedures
All consecutive adult (>18 years) patients undergoing elective
primary colorectal surgery with a planned overnight stay were
included during a single period of 2 months of recruitment
between September 15 and December 15, 2017, in all partici-
pating centers. Each patient was followed up for 30 days after
surgery. The follow-up was performed through hospital and
primary care medical records.
Data were collected using Castor EDC21 and deidentified
before entry into a secure, internet-based electronic case
record form designed specifically for POWER, which incor-
porated automated checks for plausibility, consistency, and
completeness.
The centers were considered ERAS centers if they had re-
ceived specific training in ERAS provided by the Grupo Espa-
ñol de Rehabilitación Multimodal and declared having a
multidisciplinary ERAS team and an ERAS protocol estab-
lished and approved in their center. Data describing periopera-
tive care facilities including the ERP application were col-
lected for each patient. Individual data on 22 ERP items were
collected prospectively for each included patient. The defini-
tion of the individual ERP components was based on the guide-
lines of the Enhanced Recovery After Surgery Society in colo-
rectal surgery22,23 (eTable 1 in the Supplement). Data included
patient characteristics (American Society of Anesthesiolo-
gists grade, age, sex, smoking status, body mass index, and co-
morbidities), procedure performed, surgical approach, peri-
Key Points
Question Are the complications after colorectal surgery frequent
and are the complications associated with Enhanced Recovery
After Surgery protocols?
Findings In this cohort study of 2084 patients, 566 patients
presented with moderate to severe complications. Patients
receiving care at a facility that had greater adherence to the
Enhanced Recovery After Surgery items had a lower number of
postoperative complications, regardless of whether the center had
an established Enhanced Recovery After Surgery protocol.
Meaning An increase in adherence to the Enhanced Recovery
After Surgery protocol appeared to be associated with a decrease
in postoperative complications; thus, a high adherence rate to the
Enhanced Recovery After Surgery protocol is recommended in the
management of care for patients undergoing colorectal surgery.
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operative interventions, ERP items, adherence, and outcomes
(including postoperative complications, time to achieve tar-
geted mobility, total LOS, and 30-day mortality). Complica-
tions were defined and graded as mild, moderate, or severe as
described by European Perioperative Clinical Outcome
definitions24 (eTable 2 in the Supplement) and were included
if they occurred within 30 days after surgery. Data were cen-
sored at 30 days following surgery for patients who remained
in the hospital. Data validation was conducted by the princi-
pal investigator at each site.
Outcomes
The primary outcome was the number of patients with 30-day
in-hospital moderate to severe postoperative complications. Sec-
ondary outcome measures included ERP adherence, mortality,
readmission, reoperation rates, and hospital LOS.
Statistical Analysis
We analyzed outcomes depending on whether the patient be-
longed to an ERAS program as declared by the hospital where
the intervention was performed. The discrete and continuous
variables were described as number and percentage and me-
dian (interquartile range [IQR]) and their differences analyzed
using the Fisher exact or Pearson and Wilcoxon rank sum tests.
Subsequently, we repeated the analysis, subdividing all of the
sample into quartiles according to the adherence rate to ERAS
items (regardless of whether the patients belonged to a self-
declared ERAS hospital), and comparing the quartiles of higher
and lower adherence and calculating a linear fit of the adher-
ence with the variable under study. Next, we analyzed the mod-
erate or severe complication rate for each of the ERAS items using
the Fisher exact test and performed a multivariate analysis to
study the association between the rate of each of the items and
the clinical and demographic variables. In addition, we applied
the Kaplan-Meier test to determine whether there were differ-
ences in hospital length of stay (LOS) depending on the pa-
tient’s inclusioninanERASprogramortheERASadherencequar-
tile. To avoid errors by multiple comparisons, we calculated the
respective q value for each P value to maintain a false discovery
rate below 5%.25 We considered comparisons in which P value
and q value were below .05 as being statistically significant.
Results
Participants
Data describing 2084 patients were collected in 80 Spanish hos-
pitals (Figure 1). Of these, 1286 individuals (61.7%) were men;
mean age was 68 years (IQR, 59-77). Other characteristics are
shown in the Table. In accordance with the statistical analy-
sis plan, patients from centers that recruited fewer than 10 pa-
tients were excluded from the analysis. According to the hos-
pitals where the surgery was performed, 1304 patients (62.5%)
were included in ERAS programs (Figure 2). The ERAS and non-
ERAS groups showed demographic differences in the pres-
ence of congestive heart failure; hemoglobin, albumin, and cre-
atinine levels before surgery; and cancer being the reason for
surgery (Table).
Outcome Data
A total of 879 patients (42.2%) developed postoperative com-
plications, and 566 patients (27.2%) developed complica-
tions graded as moderate or severe. The number of patients
with moderate to severe complications was lower in the ERAS
group (25.2% vs 30.3%; odds ratio [OR], 0.77; 95% CI, 0.63-
0.94; P = .01) but not in terms of overall complications, read-
mission, reoperation, or mortality rate (Figure 2). In terms of
type of complications, the ERAS group had a reduction in rates
of paralytic ileus (OR, 0.74; 95% CI, 0.57-0.95; P = .02), uri-
nary tract infection (OR, 0.51; 95% CI, 0.26-0.99; P = .04), and
infection of uncertain origin (OR, 0.45; 95% CI, 0.2-0.99;
P = .02); no significant differences were found for other spe-
cific complications (Figure 2).
ERAS Adherence and Outcome Data
The overall adherence rate to the ERAS protocol components
was 63.6% (IQR, 54.5%-77.3%), with the rate for facilities self-
declared as ERAS being 72.7% (IQR, 59.1%-81.8%) vs 59.1% (IQR,
50.0%-63.6%) at non-ERAS facilities (P < .001). In terms of ad-
herence to each item, no differences were found in the rate of
presurgical optimization, antithrombotic and antibiotic pro-
phylaxis, laparoscopic approach, and no use of nasogastric
tube; adherence was greater with other factors in the ERAS en-
vironment, for example, presurgical education (74.92% [977
of 1304] vs 47.31% [369 of 780]; P < .001), avoidance of fast-
ing (71.86% [937 of 1304] vs 46.79% [365 of 780]; P < .001), car-
bohydrates preload (39.03% [509 of 1304] vs 10.51% [82 of 780];
P < .001), avoidance of drainage (38.65% [504 of 1304]vs
28.21% [220 of 780]; P < .001) or avoidance of urinary cath-
eterization (72.85% [950 of 1304] vs 64.1% [500 of 780];
P < .001) (Table). The ERAS group also had less use of intra-
operative fluids (1500 mL [IQR, 1000-2000] vs 1500 mL [IQR,
1185-2100]; P < .001), less time to ambulation (24 hours [IQR,
20-48] vs 30 hours [IQR, 24-48]; P < .001) and oral intake (20
hours [IQR, 6-26] vs 26 hours [IQR, 24-48]; P < .001), and
shorter LOS (7 days [IQR, 5-12] vs 8 [IQR, 5-13]; P < .001)
Figure 1. STROBE Flow Diagram for Included Patients
2156 Patients in 84 hospitals
2151 In 80 hospitals
2101 Patients
2084 Included in the final analysis
17 Patients missing outcome data
50 Not recruited
16 Refused to participate
5 In another study
23 With researcher not available
6 Other
5 In 4 hospitals with <10 participants
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Table. Demographic and ERAS Adherence Dataa
Characteristic
No. (%)
P ValueTotal (N = 2084) ERAS (n = 1304) No ERAS (n = 780)
Age, median (IQR), y 68 (59-77) 68 (59-77) 69 (60-77) .78
Men 1286 (61.7) 797 (61.12) 489 (62.69) .49








I 129 (6.19) 86 (6.60) 43 (5.51)
.70
II 1153 (55.33) 718 (55.06) 435 (55.77)
III 747 (35.84) 468 (35.89) 279 (35.77)
IV 55 (2.64) 32 (2.45) 23 (2.95)
Smoking 399 (19.15) 251 (19.25) 148 (18.97) .91
Diabetes 454 (21.79) 292 (22.39) 162 (20.77) .41
Congestive heart failure 129 (6.19) 96 (7.36) 33 (4.23) .005b
Coronary artery disease 190 (9.12) 127 (9.74) 63 (8.08) .21
Cirrhosis 29 (1.39) 20 (1.53) 9 (1.15) .57
Metastasis 188 (9.02) 111 (8.51) 77 (9.87) .31
Stroke 118 (5.66) 71 (5.44) 47 (6.03) .63
COPD 306 (14.68) 197 (15.11) 109 (13.97) .52
Hypertension 1070 (51.34) 683 (52.38) 387 (49.62) .24
Previous transfusion 108 (5.18) 69 (5.29) 39 (5) .84
Hemoglobin, median (IQR), g/dL 13.2 (11.8-14.6) 13.2 (11.65-14.5) 13.3 (11.95-14.7) .03b
Leukocytes, median (IQR), /μL 6880
(5577.5-8300)
6840 (5500-8300) 6920 (5680-8400) .12
Albumin, median (IQR), g/dL 4.1 (3.8-4.4) 4.1 (3.7-4.3) 4.2 (3.8-4.5) <.001b
Creatinine, median (IQR), mg/dL 0.84 (0.71-1) 0.85 (0.72-1) 0.81 (0.7-1) .04b
Surgical procedure
Abdominoperineal amputation 112 (5.39) 72 (5.53) 40 (5.15)
.008b
Anterior rectum resection 490 (23.58) 305 (23.43) 185 (23.84)
Intestinal reconstruction 150 (7.22) 106 (8.14) 44 (5.67)
Hemicolectomy
Left 168 (8.08) 102 (7.83) 66 (8.51)
Right 582 (28.01) 361 (27.73) 221 (28.48)
Sigmoidectomy 448 (21.56) 271 (20.81) 177 (22.81)
Subtotal colectomy 59 (2.84) 39 (3.00) 20 (2.58)
TEM 10 (0.48) 1 (0.08) 9 (1.16)
Total colectomy 33 (1.59) 25 (1.92) 8 (1.03)
Transverse colectomy 26 (1.25) 20 (1.54) 6 (0.77)
Oncologic surgery 1777 (85.27) 1092 (83.74) 685 (87.82) .01b
Laparoscopic approach 1234 (59.24) 773 (59.32) 461 (59.10) .07
Ostomy 501 (24.04) 322 (24.69) 179 (22.95) .40
Analgesia
Abdominal wall block 209 (10.03) 162 (12.42) 47 (6.03) <.001 b
Epidural 642 (30.81) 455 (34.89) 187 (23.97)
Intradural 84 (34.03) 55 (4.22) 29 (3.72)
Intravenous 1149 (55.13) 632 (48.47) 517 (66.28)
ERAS adherence
Presurgical education 1346 (64.59) 977 (74.92) 369 (47.31) <.001 b
Presurgical optimization 1453 (69.72) 921 (70.63) 532 (68.21) .26
Avoid bowel preparation 1067 (51.2) 743 (56.98) 324 (41.54) <.001 b
Avoid fasting 1302 (62.48) 937 (71.86) 365 (46.79) <.001 b
Carbohydrates preload 591 (28.36) 509 (39.03) 82 (10.51) <.001 b
Avoid sedatives 1719 (82.49) 1147 (87.96) 572 (73.33) <.001 b
Antithrombotic prophylaxis 2016 (96.74) 1265 (97.01) 751 (96.28) .38
Antibiotic prophylaxis 2068 (99.23) 1295 (99.31) 773 (99.1) .61
Standardized anesthesia protocol 1447 (69.43) 1023 (78.45) 424 (54.36) <.001 b
PONV prophylaxis 1911 (91.7) 1243 (95.32) 668 (85.64) <.001 b
(continued)
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(eTable 3 in the Supplement). Among the highest adherence
quartile (Q1) and lowest adherence quartile (Q4) of ERAS items,
Q1 also had a decrease in the rate of moderate to severe
complications (OR, 0.34; 95% CI, 0.25-0.46; P < .001), over-
all complications (OR, 0.33; 95% CI, 0.26-0.43; P < .001),
and mortality (OR, 0.27; 95% CI, 0.07-0.97; P = .06), com-
pared with Q4, as well as acute kidney injury (OR, 0.56; 95%
CI, 0.29-1.28; P = .11), acute respiratory distress syndrome
(OR, 0.05; 95% CI, 0.01-0.89; P = .04), anastomotic break-
down (OR, 0.48; 95% CI, 0.28-0.81; P = .007), arrhythmia
(OR, 0.2; 95% CI, 0.04-0.9; P = .04), and superficial (OR,
0.23; 95% CI, 0.15-0.35; P < .001) and deep surgical site (OR,
Table. Demographic and ERAS Adherence Dataa (continued)
Characteristic
No. (%)
P ValueTotal (N = 2084) ERAS (n = 1304) No ERAS (n = 780)
Laparoscopic approach or minimal
incision in open surgery
1371 (65.79) 860 (65.95) 511 (65.51) .85
Avoid nasogastric tube 1231 (59.07) 790 (60.58) 441 (56.54) .07
Normothermia 2012 (96.55) 1272 (97.55) 740 (94.87) .002b
Goal-directed fluid therapy 635 (30.47) 519 (39.8) 116 (14.87) <.001b
Avoid drainage 724 (34.74) 504 (38.65) 220 (28.21) <.001b
Avoid urinary catheterization 1450 (69.58) 950 (72.85) 500 (64.1) <.001b
First 24-h fluid balance <1500 mL 1544 (74.09) 1061 (81.37) 483 (61.92) <.001b
Postoperative multimodal analgesia 1717 (82.39) 1131 (86.73) 586 (75.13) <.001b
Perioperative nutritional screening,
support
1404 (67.37) 840 (64.42) 564 (72.31) <.001b
Normoglycemia 1572 (75.43) 1072 (82.21) 500 (64.1) <.001b
Early mobilization 765 (36.71) 631 (48.39) 134 (17.18) <.001b
Early feeding 735 (35.27) 620 (47.55) 115 (14.74) <.001b
ERAS protocol, median (IQR),
% adherence
63.6 (54.5-77.3) 72.7 (59.1-81.8) 59.1 (50-63.6) <.001b
Abbreviations: ASA, American
Society of Anesthesiologists;
BMI, body mass index (calculated as
weight in kilograms divided by height
in meters squared); COPD, chronic
obstructive pulmonary disease;
ERAS, Enhanced Recovery After
Surgery; IQR, interquartile range;
PONV, postoperative nausea and
vomiting; TEM, transanal endoscopic
microsurgery.
SI conversion factors: to convert
albumin to grams per liter, multiply by
10; creatinine to micromoles per liter,
multiply by 88.4; hemoglobin to
grams per liter, multiply by 10;
leukocytes to ×109 per liters squared,
multiply by 0.001.
a A complete definition of all ERAS
item is presented in eTable 1 in the
Supplement.
b Statistically significant.
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Moderate or severe complications and type of complication in all included patients and in patients with and without the Enhanced Recovery After Surgery (ERAS)
protocol.
a Statistically significant.
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0.31; 95% CI, 0.15-0.62; P = .001) infection (Figure 3),
together with higher postsurgical levels of hemoglobin (11.6
g/dL [IQR, 10.4-12.9] vs 11.4 g/dL [IQR, 10.3-12.8]; P < .001
[to convert to grams per liter, multiply by 10]). The linear fit
of the variables against ERAS adherence confirmed the dif-
ferences between Q1 and Q4 (eFigure in the Supplement).
Multivariate analysis of ERAS items showed a statisti-
cally significant reduction of moderate to severe complica-
tions in patients who had undergone laparoscopic surgery
(OR, 0.47; 95% CI, 0.38-0.57; P < .001), presurgical educa-
tion (OR, 0.78; 95% CI, 0.64-0.95; P = .02) or optimization
(OR, 0.78; 95% CI, 0.63-0.95; P = .02); carbohydrate preload
had been implemented (OR, 0.67; 95% CI, 0.54-0.84;
P < .001), had avoided fasting (OR, 0.73; 95% CI, 0.60-0.89;
P = .002), surgical drainage tubes (OR, 0.56; 95% CI, 0.46-
0.70; P < .001), or urinary catheters (OR, 0.40; 95% CI, 0.33-
0.49; P < .001); had a fluid balance of less than 1500 mL in
the first 24 hours (OR, 0.59; 95% CI, 0.47-0.72; P < .001);
and had been mobilized (OR, 0.51; 95% CI, 0.42-0.64;
P < .001) and fed (OR, 0.47; 95% CI, 0.37-0.58; P < .001)
early; and had a significant increase in patients in whom no
antibiotic prophylaxis was performed (OR, 0.38; 95% CI,
0.14-1.03; P = .09) (Figure 4). Higher levels of albumin
(−0.08; 95% CI, −0.13 to −0.04; P < .01) and hemoglobin
(−0.07; 95% CI, −0.12 to −0.03; P < .01) were associated with
a lower incidence of moderate and severe complications
(eTable 4 in the Supplement). It was not necessary to censor
any P value after the multiple comparison study to adjust
the false discovery rate to 5%.
Hospital LOS was lower in the ERAS group compared with
the non-ERAS group (7 [IQR, 5-12] vs 8 [IQR, 5-13] days;
P < .001). Regarding the difference by adherence quartiles, Q1
presented a median LOS of 5 days, compared with 8 days in
the lowest adherence group (eTable 3 in the Supplement). The
survival study confirmed the findings of hospital LOS (eFig-
ure in the Supplement).
Discussion
This prospective observational study examined the postopera-
tive outcomes in scheduled colorectal surgery, and the out-
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Postoperative moderate to severe complications in all included patients depending on the quartile (Q) of adherence to the ERAS protocol.
a Statistically significant.
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come associated with 22 evidence-based care components of
an ERP in 80 Spanish centers and more than 2000 patients with-
out limiting the inclusion of patients to centers with an estab-
lished ERP.
A 2011 Cochrane review found that ERPs were associated
withareductioninoverallcomplicationsandLOScomparedwith
conventional perioperative care.26 The POWER study suggests
that having a defined ERP is not associated with improvements
in the postoperative outcomes; nevertheless, regardless of
whether a particular patient is involved in an established ERP,
highadherencetotheERPindividualcomponentswasassociated
with a decrease in postoperative complications and LOS.
In centers with a well-established ERP, an association be-
tween dose effect and protocol adherence and patient out-
comes has been suggested: the more that protocol compo-
nents are applied, the better the patient outcomes.9,27,28 A
negative association was shown between adherence and the
development of complications in an international data set at
13 centers at different stages of ERAS adoption including more
than 2000 patients10: less than 50% adherence, 13.1%; 75% to
90% adherence, 11.6%; and greater than 90% adherence, 9.3%.
Gustafsson and colleagues27 showed that, in facilities with 70%
or more adherence to ERAS components, the risk of 5-year can-
cer-specific death was lowered by 42% compared with the risk
in facilities with less than 70% adherence. Nevertheless, to our
knowledge, it has not been demonstrated that adherence to
an ERAS protocol in centers that do not carry out the items in
a predefined manner was associated with improvements in
outcomes.
Adherence to the ERP affects all perioperative periods.
Some of the items demonstrate high adherence in all facili-
ties, such as the laparoscopic approach, antibiotic pro-
phylaxis, antithrombotic prophylaxis, and avoidance of a
nasogastric tube; in our sample, these items can be consid-
ered as standard care. However, there are other items with
low adherence (<50%) in both ERAS and non-ERAS settings.
After retrospectively analyzing 2876 patients in an ERP in
colorectal surgery, Aarts and colleagues29 found that only
20.1% of the patients received care that fulfilled all the
phases of the ERP. The poorest adherence rate was for post-
operative interventions (40.3%) that were independently
associated with an increase in optimal recovery. This finding
confirms reports on the low adherence to protocols in the
early postoperative phase30 and is consistent with the adher-
ence found in the POWER trial for these items. In addition,
we found that 2 items—early feeding and early mobilization—
were independently associated with a decrease in moderate to
severe postoperative complications. Randomized studies31 and
observational studies32,33 demonstrated that early feeding (<24
hours postoperatively) accelerated gastrointestinal recovery and
decreased the rate of complications and the LOS.31,34 We found
that the average initial oral feeding was given less than 24 hours
postoperatively only in the quartile of highest adherence of the
ERP (adherence >77%), suggesting that a direct intervention that
allows the early initiation of oral feeding was
performed exclusively in specialized centers.
This study additionally supports the use of laparoscopic
resection within an ERAS program as an independent factor
Figure 4. Moderate to Severe Complications by Enhanced Recovery After Surgery (ERAS Items)
Moderate to Severe
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PONV indicates postoperative nausea and vomiting.
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associated with improved outcomes. Similar to previous
studies,10,19 in the multivariate analysis of our cohort, the use
of laparoscopy was independently associated with a reduc-
tion of complications by 17%.
There are reasons to believe that all components of the ERAS
program work synergistically.35 In addition, when analyzing the
association between individual items and postoperative com-
plications, it may be possible that some of the ERAS items may
influence each other, which causes difficulties in interpreta-
tion. For example, we did not find that the use of goal-directed
hemodynamic therapy reduces postoperative complications, al-
though maintaining a fluid balance less than 1500 mL on the first
postoperative day was independently associated with the de-
crease in complications. The lack of protocolization of goal-
directed hemodynamic therapy, as well as the lack of evalua-
tion of the implementation of goal-directed hemodynamic
therapy may explain these results. As with performing ERP, af-
firming that goal-directed hemodynamic therapy is conducted
is not enough; after all, avoiding volume overload has been
shown to reduce complications in multiple studies.8,19
Strengths and Limitations
This study had several strengths compared with prior stud-
ies. The first of these is the large number of consecutive
patients enrolled. Only 50 eligible patients during the study
period were not included, significantly reducing the risk of se-
lection bias, allowing a representative cross-section of the
population to be analyzed. Second, unlike other studies in-
cluding a similar number of patients, we conducted a prospec-
tive study, with a case report form specifically designed for the
study and with a 2-month recruitment period; another study
analyzed data for periods as long as 5 years.10 The changes pro-
duced in the perioperative treatment of the patients, clinical
experience of the surgeons, and even in the ERAS guidelines,
result in the patients not being comparable during such a long
period of recruitment.10
Furthermore, postoperative complications were ana-
lyzed, including centers with ERP and those without ERP, but
in which the individual components of the ERP were as-
sessed in all the patients included in the study. Despite a few
randomized clinical trials, to date, auditing of ERAS has been
largely performed in a manner similar to intention-to-treat
analysis, such that only the treatment assignment (pre-ERAS
vs ERAS) was relevant,8 or in large databases including only
patients in ERAS centers.10-12 These types of studies obtained
the same conclusions: the application of ERAS, and espe-
cially a high adherence to the protocols improve the postop-
erative outcomes. Because many of the individual items that
make up the ERP should be considered as standard care, we
decided to include centers with and without ERPs. We found
that patients who receive care in settings with high adher-
ence to the ERP had fewer postoperative complications and
shorter LOS; however, this was independent of the existence
of an ERP in a certain center.
The POWER study has some limitations. Because care was
not randomly assigned, there may be residual confounding
from either measured or unmeasured variables. Further-
more, although we defined all ERAS items in the POWER pro-
tocol, we cannot rule out measurement errors or misclassifi-
cation on the part of the researchers, especially in some
elements of the ERP, such as fluid balance in the first 24 hours,
which implied more complex measurements and in which
there could be a lack of information in the patients' medical
records. In addition, the current recommendations on some
items are different from those that we used; for example, we
defined the avoidance of mechanical bowel preparation as part
of adherence to the ERP,22,23 while the most recent guide-
lines recommend performing it.35 Therefore, it is possible that
when reversing the definition of the item, the results may be
different. However, there are interrelated items: we have found
that avoiding urinary catheterization and surgical drains was
associated with a reduction of complications by 20% and 11%
in the multivariate analysis respectively; however, it is pos-
sible that both the presence of a urinary catheter and the in-
sertion of surgical drains were directly related to the patients
who presented complications, as a measure of treatment or pro-
phylaxis. Further studies are necessary to evaluate the effect
of ERP on longer-term outcomes, especially functional and cog-
nitive ability after surgery.
Conclusions
This study suggests that ERP in colorectal surgery is not fully
applied in daily clinical practice. In addition, there are certain
elements of the ERP that have low adherence, even in special-
ized ERAS centers. Postoperative recovery is mainly associ-
ated with the minimally invasive surgical approach and the
postoperative components, such as early oral intake and early
ambulation. Therefore, adherence to these items is recom-
mended to be mandatory in future ERAS programs. The
POWER study shows that having a protocol is not enough to
improve outcomes, but an increase in adherence to ERAS items
is associated with a decrease in postoperative complications;
therefore, continuous auditing of adherence to ERAS and post-
operative outcomes is essential.
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